Illumina
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Illumina and other ETFs, options, and stocks.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
ILMN News
Text size It’s the quiet before the storm of third-quarter earnings season, which ramps up during the second week of October. The main event on the economic ca...
Text size Bill Gates speaks onstage at the TIME100 Summit in 2022. Jemal Countess/Getty Images for TIME A thousand medical researchers and doctors gathered in...
Competition is intensifying in the DNA sequencing industry, which has long been dominated by sequencing behemoth Illumina. Driving the news: Illumina, which ha...
Analyst ratings
50%
of 18 ratingsILMN Earnings
More ILMN News
(Bloomberg) -- Illumina Inc. says it can read a person’s entire genetic code for as little as $200 with its new sequencing machine, bringing the company within...
Text size Surrounded by challengers promising faster, cheaper gene-sequencing systems, industry leader Illumina announced its own faster, cheaper gene-readers...
The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo SAN DIEGO,...
The human genome is made of more than 6 billion letters, and each person has a unique configuration of As, Cs, Gs, and Ts—the molecular building blocks that mak...
Check out the companies making headlines in midday trading. Apple — Apple shares fell 3.4% on Wednesday following a report that the company is ditching plans t...
Text size Illumina ’s gene sequencers powered many of the recent breakthroughs in biology and medicine, but the San Diego-based firm hasn’t introduced a new pr...
The Justice Department's failed attempt to block UnitedHealth's $13 billion acquisition of health tech Change Healthcare could bode well for other mega-deals as...
